Background Olaparib, a poly(ADP-ribose) polymerase (PARP) inhibitor, has previously shown
efficacy in a phase 2 study when given in capsule formulation to all-comer patients with …

Objective There is a need to develop and validate biomarkers for treatment response and
survival in tubo-ovarian high-grade serous carcinoma (HGSC). The chemotherapy response …

Background Olaparib, a poly (ADP-ribose) polymerase (PARP) inhibitor, has previously
been shown to extend progression-free survival versus placebo when given to patients with …

Endometrial cancer frequently occurs in post-menopausal women, and the endometrium is
a well-known site of cancer affecting women. Endometrial cancer is found with genital …

The purpose of this study was to determine the safety, distribution, internal dosimetry, and
initial human epidermal growth factor receptor 2 (HER2)–positive tumor images of 64 Cu-…

Although cancer diagnosed during pregnancy is rare, epithelial cell type ovarian cancers (EOCs)
comprise approximately one quarter to one half of cases of ovarian malignancy …

Background The long-term outcomes and risk factors of paclitaxel-induced peripheral
neuropathy (PIPN) have not yet been fully elucidated. Methods We identified 219 breast cancer …

Background The presence of tumour-infiltrating lymphocytes (TILs) is a favourable prognostic
factor in patients with early breast cancer. Programmed cell death-1 (PD-1) and its ligand …

Patients with triple‐negative breast cancers ( TNBC s) typically have a poor prognosis
because such cancers have no effective therapeutic targets, such as estrogen receptors for …

Background The purpose of this study was to determine whether brain metastases from
HER2-positive breast cancer could be detected noninvasively using positron emission …